Royalty Report: Food, Beverages, Medical – Collection: 248344


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 4


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4

Primary Industries

  • Food
  • Beverages
  • Medical
  • Drugs
  • Nutraceutical
  • Supplements
  • Nutrition
  • Dental

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 248344

License Grant
Seller shall sell, assign, transfer and convey to Buyer, and Buyer shall purchase, acquire and accept from each Seller, the business of the respective Sellers as a going concern (the 'Business'), including all of the Sellers assets of every kind and description as set forth hereto (the Purchased Assets).

Part of the conditions to obligations of the sellers and the stockholder, each Seller and the Stockholder to consummate this Agreement and the transactions contemplated hereby (Form of License Agreement) are subject to the fulfillment, prior to or at the Closing, of the following conditions precedent

License grant by Buyer   Buyer shall have executed and delivered to Seller an exclusive, perpetual, assignable, fully paid-up, royalty-free license to use the Seller IP solely for liquid beverages (including 'shooters') in substantially the form of the 'Seller Pharmaceutical License Agreement'.

Licensor (Buyer) hereby grants to Licensee (Seller), subject to the terms and conditions of this Agreement, a fully paid-up and royalty- free right and exclusive license, including the right to grant sublicenses, under the Patent Rights to make, have made, use and sell Licensed Products in the field during the term in the territory.

In the event that Buyer obtains revenue or other measurable economic benefit ('Gross Revenues') from products or services covered by a Valid Claim.

License Property
Patent Rights shall mean Licensor intellectual property described below
The United States and foreign patents / applications
United States            Patent Appln. No. 09/584,220       Filed May 31, 2000
United States            Patent Appln. No. 09/962,514       Filed September 24, 2001
United States            Patent Appln. No. 10/396,117       Filed March 25, 2003
Field of Use
Field shall mean the development, manufacture and sale of kava kava extracts, and components thereof, for use in beverages and drink formulations.

IPSCIO Record ID: 5305

License Grant
Seller shall sell, convey, transfer, and deliver to the Purchaser all right, title and interest to all of the intellectual property developed by Seller in connection with the formulas for Seller's health food bar and health drink.
License Property
The Seller has developed certain formulas for the creation of a health food bar and health drink and has invested considerable time, effort and expense in the development of these formulas
Field of Use
Purchaser desires to purchase all of the intellectual property developed by Seller in connection with Seller's formulas for a health food bar and health drink.

IPSCIO Record ID: 281604

License Grant
Buyer shall purchase from the Seller, and the Seller shall sell, assign, transfer, convey, and deliver to Buyer, all of each Seller’s right, title and interest in and to all of the following assets, properties, and rights (the Acquired Assets).
License Property
Business means the business of conducting research and development as well as manufacturing and marketing nutritional supplements, as conducted by the Seller on the Closing Date.

The Acquired Assets include but not limited to Intellectual Property, Inventory, Books and records.

All Intellectual Property, associated goodwill, related licenses and sublicenses (in each case, whether granted or obtained) and other rights, remedies against infringements of, and rights to protect interests in Intellectual Property, which includes all of each Seller’s rights in its trade names, registered and unregistered trademarks, service marks, domain names, and patents.

Field of Use
This agreement pertains to the medical industry.

IPSCIO Record ID: 732

License Grant
Buyer hereby grants to Irish Seller, a non-exclusive license to use the Intellectual Property solely with respect to the Irish Business and in a manner consistent with the use of the Intellectual Property by Irish Seller immediately prior to the U.S. Closing.
License Property
Irish Sellers are engaged in the manufacture, development and distribution of dental products including disposable applicators and related products and services (collectively, the Business).  Buyers desire to purchase from Sellers, and Sellers desire to sell to Buyers the Purchased Assets (as defined below) on the terms and conditions set forth herein.  The Stockholders will benefit from the sale of the Purchased Assets and have agreed to be bound by the provisions of this Agreement, including the noncompetition covenant, exclusivity provision and indemnification provision herein.
Field of Use
The rights granted apply to dental products.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.